Thoma Capital Management LLC Makes New Investment in Oracle Co. (NYSE:ORCL)

Thoma Capital Management LLC bought a new position in shares of Oracle Co. (NYSE:ORCLFree Report) in the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund bought 5,526 shares of the enterprise software provider’s stock, valued at approximately $921,000. Oracle comprises approximately 0.6% of Thoma Capital Management LLC’s portfolio, making the stock its 21st biggest position.

Several other large investors have also made changes to their positions in ORCL. Norges Bank bought a new stake in Oracle in the fourth quarter valued at about $2,216,314,000. Raymond James Financial Inc. acquired a new position in shares of Oracle in the 4th quarter valued at approximately $930,095,000. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC boosted its holdings in shares of Oracle by 20.5% in the fourth quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 13,825,360 shares of the enterprise software provider’s stock valued at $2,303,858,000 after buying an additional 2,350,448 shares during the period. Vanguard Group Inc. raised its stake in shares of Oracle by 1.5% in the 4th quarter. Vanguard Group Inc. now owns 157,411,949 shares of the enterprise software provider’s stock valued at $26,231,127,000 after purchasing an additional 2,296,069 shares during the period. Finally, Kovitz Investment Group Partners LLC boosted its position in Oracle by 268.4% during the 4th quarter. Kovitz Investment Group Partners LLC now owns 3,077,947 shares of the enterprise software provider’s stock worth $512,909,000 after acquiring an additional 2,242,520 shares during the last quarter. Institutional investors and hedge funds own 42.44% of the company’s stock.

Wall Street Analyst Weigh In

A number of research analysts recently weighed in on the stock. Jefferies Financial Group decreased their target price on shares of Oracle from $220.00 to $190.00 and set a “buy” rating for the company in a research report on Monday, March 31st. Guggenheim reaffirmed a “buy” rating and issued a $220.00 target price on shares of Oracle in a research report on Thursday, April 3rd. Monness Crespi & Hardt upgraded Oracle from a “sell” rating to a “neutral” rating in a research note on Monday, March 3rd. DA Davidson cut their price objective on Oracle from $150.00 to $140.00 and set a “neutral” rating for the company in a report on Monday, April 14th. Finally, KeyCorp restated an “overweight” rating and set a $200.00 target price on shares of Oracle in a report on Tuesday, March 11th. Fourteen equities research analysts have rated the stock with a hold rating, fifteen have assigned a buy rating and one has issued a strong buy rating to the stock. Based on data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and a consensus price target of $174.42.

Check Out Our Latest Analysis on Oracle

Insiders Place Their Bets

In other news, Director Naomi O. Seligman sold 2,866 shares of the company’s stock in a transaction dated Monday, May 5th. The shares were sold at an average price of $149.53, for a total transaction of $428,552.98. Following the transaction, the director now owns 31,764 shares in the company, valued at approximately $4,749,670.92. This represents a 8.28% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, Director Leon E. Panetta sold 5,000 shares of the stock in a transaction dated Friday, April 11th. The stock was sold at an average price of $129.77, for a total transaction of $648,850.00. Following the transaction, the director now directly owns 58,090 shares in the company, valued at $7,538,339.30. This trade represents a 7.93% decrease in their position. The disclosure for this sale can be found here. In the last ninety days, insiders sold 27,366 shares of company stock worth $4,015,723. Company insiders own 42.20% of the company’s stock.

Oracle Price Performance

Oracle stock opened at $161.84 on Wednesday. The stock has a 50-day moving average price of $143.94 and a two-hundred day moving average price of $161.60. Oracle Co. has a 12 month low of $114.55 and a 12 month high of $198.31. The company has a market capitalization of $452.66 billion, a PE ratio of 39.57, a P/E/G ratio of 3.46 and a beta of 1.27. The company has a current ratio of 0.81, a quick ratio of 0.81 and a debt-to-equity ratio of 5.65.

Oracle (NYSE:ORCLGet Free Report) last issued its quarterly earnings results on Monday, March 10th. The enterprise software provider reported $1.47 EPS for the quarter, missing analysts’ consensus estimates of $1.49 by ($0.02). The business had revenue of $14.13 billion for the quarter, compared to analyst estimates of $14.40 billion. Oracle had a return on equity of 133.25% and a net margin of 21.16%. Oracle’s revenue for the quarter was up 6.4% on a year-over-year basis. During the same quarter last year, the firm posted $1.41 EPS. Analysts expect that Oracle Co. will post 5 EPS for the current year.

Oracle Increases Dividend

The company also recently declared a quarterly dividend, which was paid on Wednesday, April 23rd. Shareholders of record on Thursday, April 10th were given a dividend of $0.50 per share. The ex-dividend date of this dividend was Thursday, April 10th. This represents a $2.00 dividend on an annualized basis and a yield of 1.24%. This is a boost from Oracle’s previous quarterly dividend of $0.40. Oracle’s dividend payout ratio is 46.95%.

Oracle Company Profile

(Free Report)

Oracle Corporation offers products and services that address enterprise information technology environments worldwide. Its Oracle cloud software as a service offering include various cloud software applications, including Oracle Fusion cloud enterprise resource planning (ERP), Oracle Fusion cloud enterprise performance management, Oracle Fusion cloud supply chain and manufacturing management, Oracle Fusion cloud human capital management, Oracle Cerner healthcare, Oracle Advertising, and NetSuite applications suite, as well as Oracle Fusion Sales, Service, and Marketing.

Featured Stories

Want to see what other hedge funds are holding ORCL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Oracle Co. (NYSE:ORCLFree Report).

Institutional Ownership by Quarter for Oracle (NYSE:ORCL)

Receive News & Ratings for Oracle Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Oracle and related companies with MarketBeat.com's FREE daily email newsletter.